Join the 200th Anniversary Celebration

Browse Global Health

Showing 1 to 20 of 397 Articles

Sort By:

  • Perspective

    Human immunodeficiency virus type 1 (HIV-1) and hepatitis B virus (HBV) exact a high toll worldwide. Both can lead to chronic disease, cancer, and death, and neither can be eradicated with the use of current therapies. Antiviral drug resistance often develops after patients have received treatment…

    • May 10, 2012
    • Kourtis A.P., Bulterys M., Hu D.J., Jamieson D.J.
    • N Engl J Med 2012; 366:1749-1752
    • Free Full Text

    Human immunodeficiency virus and hepatitis B virus exact a high toll worldwide. Both can lead to chronic disease, cancer, and death, and neither can be eradicated with the use of current therapies. Coinfection with the two viruses represents a major global health problem.

  • Perspective

    Barely 20 years ago, such a high proportion of childhood deaths globally was attributable to measles that the going estimate of more than 1 million measles-related deaths per year was almost certainly an underestimate. Pediatric wards in the developing world were filled with patients with measles…

    • May 10, 2012
    • Mulholland E.K., Griffiths U.K., Biellik R.
    • N Engl J Med 2012; 366:1755-1757
    • Interactive/Multimedia

    Between 2000 and 2008, measles control improved markedly worldwide, but with poorer countries focused on polio eradication and some richer countries falling prey to opposition to vaccination, the measles genie seems to have slipped out of the bottle in recent years.

  • Original Article

    Approximately 25% of the world's population is infected with intestinal helminths. These neglected tropical infections disproportionately affect the world's least privileged and most vulnerable populations and are among the most common medical conditions in refugees.– Among resettled refugees,…

    • April 19, 2012
    • Swanson S.J., Phares C.R., Mamo B., et al.
    • N Engl J Med 2012; 366:1498-1507

      To reduce intestinal helminths among refugees arriving in the United States, the CDC has recommended albendazole therapy before departure. Among African and Southeast Asian refugees in Minnesota, albendazole reduced the proportion with stool nematodes from 20.8% to 4.7%.

    • Review Article

      Dengue is a self-limited, systemic viral infection transmitted between humans by mosquitoes. The rapidly expanding global footprint of dengue is a public health challenge with an economic burden that is currently unmet by licensed vaccines, specific therapeutic agents, or efficient vector-control…

      • April 12, 2012
      • Simmons C.P., Farrar J.J., van Vinh Chau N., Wills B.
      • N Engl J Med 2012; 366:1423-1432
      • CME

      There are an estimated 50 million infections per year with the dengue virus, which is transmitted primarily by urban-adapted Aedes aegypti mosquitoes. This review summarizes pathophysiology and treatment as well as prospects for a vaccine and for vector-control approaches.

    • Original Article

      Artemisinin-based combination therapy is critical for the effective treatment and control of Plasmodium falciparum malaria.– However, reports from the Cambodian–Thai border indicate the emergence of artemisinin tolerance or resistance in P. falciparum.– Pyronaridine–artesunate is a fixed…

      • April 5, 2012
      • Rueangweerayut R., Phyo A.P., Uthaisin C., et al.
      • N Engl J Med 2012; 366:1298-1309
      • CME

      New therapies to treat malaria are needed. In this report, in which the authors studied 1271 patients from Asia and Africa, pyronaridine–artesunate was found to be noninferior to mefloquine plus artesunate in the treatment of uncomplicated Plasmodium falciparum malaria.

    • Editorial

      During the 30 years since the discovery of HIV as the cause of AIDS, efforts to develop a vaccine have faced immense challenges. First, naturally acquired immunity to protect against infection that results in disease, found with virtually all other known infectious agents, may not exist for HIV.…

      • April 5, 2012
      • Baden L.R. and Dolin R.
      • N Engl J Med 2012; 366:1343-1344

        During the 30 years since the discovery of HIV as the cause of AIDS, efforts to develop a vaccine have faced immense challenges. First, naturally acquired immunity to protect against infection that results in disease, found with virtually all other known ...

      • Original Article

        Podoconiosis (endemic nonfilarial elephantiasis) is a noninfectious geochemical disease that results in bilateral swelling of the lower legs (Figure 1). It is found among subsistence farmers whose feet are exposed over many years to red-clay soil derived from volcanic rock. Podoconiosis is an…

        • March 29, 2012
        • Tekola Ayele F., Adeyemo A., Finan C., et al.
        • N Engl J Med 2012; 366:1200-1208

          Podoconiosis is a tropical form of noninfectious lymphedema associated with exposure to red-clay soil. It affects over 4 million people and is associated with substantial morbidity. In this genomewide association study in Ethiopia, associations were identified in two HLA class II loci.

        • Perspective

          There are two principal causes of elephantiasis, or lymphedema, in the tropics. The most common cause and a significant public health problem is lymphatic filariasis due to the parasitic nematode Wuchereria bancrofti (and, in Asia, Brugia malayi and B. timori), which is transmitted by mosquitoes.…

          • March 29, 2012
          • Molyneux D.H.
          • N Engl J Med 2012; 366:1169-1171

            Lymphedema in the tropics has two main causes: lymphatic filariasis caused by the parasitic nematode Wuchereria bancrofti, transmitted by mosquitoes, and podoconiosis, caused by microsilica particles from red-clay volcanic soil that enter the skin of the feet.

          • Perspective

            On August 31, 2011, a 24-year-old soldier from California died from complications of rabies treatment. He was infected months earlier, from a dog bite he sustained in Afghanistan. His death provides a glimpse of the risk of disease and non-battle injuries that service members face in war. Although…

            • February 23, 2012
            • Chretien J.-P.
            • N Engl J Med 2012; 366:677-679

              Although traumatic brain injury and traumatic amputations may be signature wounds of the Afghanistan and Iraq wars, the toll on military personnel from diseases and nonbattle injuries is substantial — and largely preventable. The critical element is command support.

            • Perspective

              It is time to sound the alarm. During the past 3 years, the wily gonococcus has become less susceptible to our last line of antimicrobial defense, threatening our ability to cure gonorrhea and prevent severe sequelae. Gonorrhea is the second most commonly reported communicable disease in the United…

              • February 9, 2012
              • Bolan G.A., Sparling P.F., Wasserheit J.N.
              • N Engl J Med 2012; 366:485-487

                Gonorrhea, which disproportionately affects marginalized populations, is the second most commonly reported communicable disease in the United States. Over the past 3 years, the gonococcus has shown decreased susceptibility to our last line of antimicrobial defense.

              • Editorial

                Every new episode of tuberculosis — there were 9 million in 2010 — follows a period of asymptomatic infection lasting from weeks to decades. These subclinical infections, which are detectable with a tuberculin skin test or interferon-γ release assay, offer a target for prophylactic treatment…

                • December 8, 2011
                • Dye C.
                • N Engl J Med 2011; 365:2230-2231

                  Every new episode of tuberculosis — there were 9 million in 20101 — follows a period of asymptomatic infection lasting from weeks to decades. These subclinical infections, which are detectable with a tuberculin skin test or interferon-γ release assay, ...

                • Original Article

                  Tuberculosis results in nearly 2 million deaths annually worldwide. More than 2 billion persons are infected with Mycobacterium tuberculosis, and from this reservoir active tuberculosis will develop in millions of persons in coming decades. Treatment of latent M. tuberculosis infection among the…

                  • December 8, 2011
                  • Sterling T.R., Villarino M.E., Borisov A.S., et al.
                  • N Engl J Med 2011; 365:2155-2166
                  • CME

                  Treatment of latent TB is an important public-health strategy, but 9 months of daily isoniazid (270 doses) poses challenges for compliance. In this study, 3 months of weekly isoniazid plus rifapentine (12 doses) was found to be noninferior to 9 months of isoniazid alone.

                • Perspective

                  Somalia has been in the grips of disaster for two decades. Throughout this past summer, the human catastrophe dramatically worsened. War and drought have driven hundreds of thousands of people from their homes in south and central Somalia, with some families walking for more than a week across the…

                  • November 17, 2011
                  • Cabrol J.-C.
                  • N Engl J Med 2011; 365:1856-1858
                  • Free Full Text
                  • Slideshow

                  Somalia has been in the grips of disaster for two decades. Throughout this past summer, the human catastrophe dramatically worsened. Severe malnutrition and measles are rampant among Somali refugees in Kenya and Ethiopia and internally displaced people within Somalia.

                • Original Article

                  Each year, malaria occurs in approximately 225 million persons worldwide, and 781,000 persons, mostly African children, die from the disease. During the past decade, the scale-up of malaria-control interventions has resulted in considerable reductions in morbidity and mortality associated with…

                  • November 17, 2011
                  • The RTS,S Clinical Trials Partnership
                  • N Engl J Med 2011; 365:1863-1875
                  • Free Full Text

                  Each year, about 225 million persons have malaria, with some 781,000 associated deaths. In a preliminary report of a phase 3 trial in African children, the RTS,S/AS01 malaria vaccine had about 50% efficacy against incident malaria and 34% efficacy against severe disease.

                • Editorial

                  It's been a long time coming, and indeed we are still not there yet, but it is becoming increasingly clear that we really do have the first effective vaccine against a parasitic disease in humans. If there are no unforeseen disasters, the RTS,S/AS01 Plasmodium falciparum malaria vaccine should…

                  • November 17, 2011
                  • White N.J.
                  • N Engl J Med 2011; 365:1926-1927
                  • Free Full Text

                  It's been a long time coming, and indeed we are still not there yet, but it is becoming increasingly clear that we really do have the first effective vaccine against a parasitic disease in humans. If there are no unforeseen disasters, the RTS,S/AS01 ...

                • Review Article

                  Each year, hepatocellular carcinoma is diagnosed in more than half a million people worldwide, including approximately 20,000 new cases in the United States. Liver cancer is the fifth most common cancer in men and the seventh in women. Most of the burden of disease (85%) is borne in developing…

                  • September 22, 2011
                  • El-Serag H.B.
                  • N Engl J Med 2011; 365:1118-1127
                  • CME

                  Each year, more than half a million people worldwide receive a diagnosis of hepatocellular carcinoma, and hepatocellular carcinoma related to HCV is the fastest rising cause of U.S. cancer-related deaths. This review summarizes recent advances in prevention, surveillance, diagnosis, and treatment.

                • Perspective

                  In the 1970s, Chinese government scientists working on a secret "Project 523" developed a new class of potent antimalarial drugs, the artemisinins or qinghaosu derivatives. In mostly unpublished work that has just been recognized by a 2011 Lasker Award to Tu Youyou, researchers in China isolated…

                  • September 22, 2011
                  • Dondorp A.M., Fairhurst R.M., Slutsker L., et al.
                  • N Engl J Med 2011; 365:1073-1075
                  • Free Full Text

                  Since the 1970s, when Chinese researchers demonstrated the artemisinins' antimalarial potency, artemisinin-based combination therapy has become key to malaria control. But reduced susceptibility of Plasmodium falciparum to artemisinin is now being seen in some places.

                • Original Article

                  An effective malaria vaccine would improve the prospects for eradicating malaria. Vaccines that interrupt the transmission of malaria are emphasized in discussions of eradication, but the ideal malaria vaccine would provide a direct clinical benefit. Vaccines targeting the blood stages of malaria…

                  • September 15, 2011
                  • Thera M.A., Doumbo O.K., Coulibaly D., et al.
                  • N Engl J Med 2011; 365:1004-1013
                  • Free Full Text

                  In this study of 400 children in Mali, an adjuvanted vaccine based on an apical membrane antigen 1 from the 3D7 strain of Plasmodium falciparum (a blood-stage antigen) showed some strain-specific activity in preventing clinical malaria.

                • Correspondence

                  To the Editor: In 2007, we conducted a double-blind, randomized, phase 1b clinical trial (ClinicalTrials.gov number, NCT00452088) using the merozoite surface protein 3 (MSP3) vaccine in a malaria-endemic area. A total of 45 children who were 12 to 24 months of age were randomly assigned in a 1:1:1…

                  • September 15, 2011
                  • N Engl J Med 2011; 365:1062-1064
                  • Free Full Text

                  Malaria is a leading cause of illness and death in the developing world. Thus, the need for an effective vaccine is great. In this phase 1 trial in Burkina Faso, a merozoite surface protein–based vaccine showed some evidence of protection against clinical malaria.

                • Correspondence

                  To the Editor: The World Health Organization (WHO) recommends the use of rotavirus vaccines for all children worldwide to control severe rotavirus disease, which causes 527,000 childhood deaths annually. After the phased national introduction of rotavirus vaccine in Mexico in 2006 and 2007, we…

                  • August 25, 2011
                  • N Engl J Med 2011; 365:772-773
                  • Free Full Text

                  Rotavirus is associated with substantial global mortality and morbidity. The use of the rotavirus vaccine is associated with a sustained decrease in the rate of death related to childhood diarrhea in Mexico.

                Page

                Medical Meetings Pediatrics Conferences and Meetings

                2012 Certifying Examinations of the American Board of Pediatrics

                The general pediatrics examination will be held in various cities, Oct. 16-18. Registration for first-time applicants is ongoing through May 3. Registration for re-registrants is ongoing through May 24. The following subspecialty examinations will be held in various cities: "Hospice and Palliative Medicine" (Oct. 4); "Pediatric Transplant Hepatology" (Oct. 11); "Pediatric Cardiology" (Nov. 7); "Pediatric Pulmonology" (Nov. 8); "Medical Toxicology" (Nov. 12); and "Pediatric Critical Care Medicine" (Nov. 14). Registration for first-time applicants is ongoing through April 30. Registration for re-registrants is ongoing through June 15.

                Contact the American Board of Pediatrics, 111 Silver Cedar Court, Chapel Hill, NC 27514-1513; or call (919) 929-0461; or fax (919) 918-7114 or (919) 929-9255; or see http://www.abp.org .

                More Medical Meetings